Table 1.
MALES | Vehicle | Statin | 2-way ANOVA | ||||
---|---|---|---|---|---|---|---|
WT | Scly KO | WT | Scly KO | Pint | PStatin | PGen | |
GPX act serum (nmol/mL−1) | 40.7±1.5 | 43.0±2.4 | 41.0±1.0 | 41.9±1.0 | 0.342 | 0.6052 | 0.0399 |
GPX act liver (nmol/mg1) | 1.24±0.04 | 1.20±0.04 | 1.17±0.03 | 1.23±0.05 | 0.0132 | 0.2036 | 0.6066 |
HNE serum (μg/mL) | 3.4±1.6 | 8.5±8.2* | 2.6±1.6 | 5.0±3.4*# | 0.4234 | 0.2151 | 0.0322 |
HNE liver (μg/mL) | 12.8±5.4# | 18. 9±10.9 | 6.2±3.5 | 7.3±4.1# | 0.3531 | 0.0023 | 0.1874 |
FEMALES | Vehicle | Statin | 2-way ANOVA | ||||
WT | Scly KO | WT | Scly KO | Pint | PStatin | PGen | |
GPX act serum (nmol/mL−1) | 49.4±1.2 | 52.0±1.0 | 46.7±0.9 | 50.9±1.9* | 0.1945 | 0.0053 | <0.0001 |
GPX act liver (nmol/mg1) | 1.33±0.11 | 1.25±0.04 | 1.26±0.07 | 1.23±0.04 | 0.3226 | 0.1726 | 0.093 |
HNE serum (μg/mL) | 3.9±1.4 | 7.7±4.4* | 3.4±0.8 | 5.6±2.2*# | 0.4948 | 0.2437 | 0.0157 |
HNE liver (μg/mL) | 14.5±14.2 | 31.7±16.7* | 11.1±3.7 | 9.4±3.6# | 0.0504 | 0.014 | 0.1148 |
Values are mean ± SEM. Two-way analysis of variance (ANOVA) was applied, followed by a Bonferroni post hoc test. Italicized numbers represent P<0.05 after 2-way ANOVA.
represents P <0.05 between Scly KO and WT, and
represents within the same genotype groups after post hoc test. P-values under 0.05 deemed significant; n = 5–8 per group. WT: wild type, KO: knockout; GPX: glutathione peroxidase, HNE: 4-Hydroxy-Trans-2-Nonenal; Act: activity; Int: interaction; Gen: genotype.